Legal Representation
Attorney
ERICA HALSTEAD
USPTO Deadlines
Next Renewal Deadline
Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-25)
Due: February 25, 2026
(233 days remaining)
Grace period ends: August 25, 2026
Additional renewal deadlines exist. Contact your attorney for complete deadline information.
Application History
37 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 25, 2025 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Jul 22, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 22, 2022 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Jul 22, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jul 22, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jul 17, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Jun 25, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Jun 25, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| May 25, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Feb 25, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Dec 20, 2019 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Dec 10, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 10, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 4, 2019 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Dec 4, 2019 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Nov 20, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 6, 2019 | ALIE | A | ASSIGNED TO LIE |
| Nov 5, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 15, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Oct 15, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Oct 15, 2019 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Oct 11, 2019 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| May 29, 2019 | CNFR | O | FINAL REFUSAL MAILED |
| May 28, 2019 | CNFR | R | FINAL REFUSAL WRITTEN |
| May 7, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| May 7, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| May 6, 2019 | ALIE | A | ASSIGNED TO LIE |
| Apr 29, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Nov 17, 2018 | RFNT | P | REFUSAL PROCESSED BY IB |
| Oct 31, 2018 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Oct 31, 2018 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Oct 17, 2018 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Oct 16, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 13, 2018 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Oct 9, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 9, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 4, 2018 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Pharmaceutical products, namely, delivery agents in the form of a particle coating for pills and tablets for effective taste masking and ease of swallowing; pharmaceutical products, namely, delivery agents in the form of particle functionalization powders that provide modified and controlled release of medicinal preparations; pharmaceutical adjuvants for medical purposes; capsules for medicines, namely, capsules sold empty for pharmaceuticals; dietary supplements for medical use and dietary food preparations, namely, dietetic foods adapted for medically controlled nutrition; dietary sweeteners for medical use, namely, dietetic sugar substitutes for medical use; clinical nutrition, namely, dietetic foods adapted for medical use; vitamin supplements; dietary supplements composed mainly of calcium; medicated food supplements; multivitamin preparations; protein-based food supplements; dietary supplements composed of trace elements; food supplements consisting of vitamins
Class 042
Chemical analysis; research in the field of pharmaceutical chemistry; research in the field of galenic pharmacy; research and design of new oral forms of medicinal products for others in the pharmaceutical field; design of new products for others in the field of galenic pharmacy; technological consulting services in the fields of pharmaceutical studies, research and development; quality control for others in the field of galenic pharmacy; conducting clinical trials for others on new pharmaceutical dosage forms; material testing in the field of galenic pharmacy; engineering in the pharmaceutical field; research and development of new products for others in the pharmaceutical field; research and development of new products for others in the pharmaceutical field, namely, research and development of oral forms of medicines; biological research services; technical and scientific advice in the field of pharmaceutical research to the pharmaceutical industry; research and design of new products in the fields of medical food and dietetics
Classification
International Classes
005
042